FMCQF OTC
Fresenius Medical Care AG
1W: +9.6%
1M: +8.2%
3M: +10.4%
YTD: +5.0%
1Y: -6.3%
3Y: +9.3%
5Y: -32.5%
$43.01
-5.84 (-11.95%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$11.6B
52W Range42-56.24
Volume2,000
Avg Volume51
Beta0.82
Dividend$1.73
Analyst Ratings
Company Info
CEOHelen Giza
Employees108,165
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2012-02-07
Websitefreseniusmedicalcare.com
Else-Kröner-Strasse 1
Bad Homburg, HE 61352
DE
Bad Homburg, HE 61352
DE
49 6172 608 2522
About Fresenius Medical Care AG
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Latest News
Fresenius Medical Care (ETR:FME) Shares Pass Above 200 Day Moving Average – Should You Sell?
Fresenius Medical Care Non-GAAP EPS of €0.91, revenue of €4.61B; reconfirms FY26 outlook
DaVita tops chart as the only large-cap healthcare services name rated Strong Buy
Fresenius Medical Care Non-GAAP EPS of Є1.44, revenue of Є5.07B; introduces FY26 and long-term outlook
Recent Insider Trades
No insider trades found